Advertisement
Screener

SERACARE LIFE SCIENCES INC Research and Development Expense

SERACARE LIFE SCIENCES INC Research and Development Expense

SERACARE LIFE SCIENCES INC reported Research and Development Expense of $412.23 thousand for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2012-02-10

  • SERACARE LIFE SCIENCES INC research and development expense for the quarter ending 2011-12-31 was $412.23K, a 33.30% increase year-over-year.
  • SERACARE LIFE SCIENCES INC research and development expense for the quarter ending 2011-09-30 was $427.47K, a 82.08% increase year-over-year.
  • SERACARE LIFE SCIENCES INC research and development expense for the quarter ending 2011-06-30 was $303.78K, a 44.18% increase year-over-year.
  • SERACARE LIFE SCIENCES INC research and development expense for the quarter ending 2010-12-31 was $309.25K.
  • SERACARE LIFE SCIENCES INC research and development expense for fiscal 2011 was $1.28M, a 64.33% increase from fiscal 2010.
  • SERACARE LIFE SCIENCES INC research and development expense for fiscal 2010 was $777.07K, a 30.75% decline from fiscal 2009.
  • SERACARE LIFE SCIENCES INC research and development expense for fiscal 2009 was $1.12M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2011-12-31$412.23K
10-Q · filed 2012-02-10
$839.70K
derived: sum of 2 quarters · filed 2012-02-10
$1.14M
derived: sum of 3 quarters · filed 2012-02-10
2011-09-30$427.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-21
$731.25K
derived: sum of 2 quarters · filed 2011-11-21
$1.28M
10-K · filed 2011-11-21
2011-06-30$303.78K
10-Q · filed 2011-07-26
$849.48K
10-Q · filed 2011-07-26
2010-12-31$309.25K
10-Q · filed 2012-02-10
$544.01K
derived: sum of 2 quarters · filed 2012-02-10
$754.71K
derived: sum of 3 quarters · filed 2012-02-10
2010-09-30$234.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-21
$445.46K
derived: sum of 2 quarters · filed 2011-11-21
$777.07K
10-K · filed 2011-11-21
2010-06-30$210.69K
10-Q · filed 2011-07-26
$542.30K
10-Q · filed 2011-07-26
2009-09-30$1.12M
10-K · filed 2011-11-21